Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 992 results for "hepatitis"

Second WA berry-linked hepatitis A case confirmed
WA Today

Hepatitis A cases rise to 26

An update from the federal health department on Wednesday added three more cases — two in Queensland and another in WA. The source of the hepatitis A virus is still unconfirmed. However, the berries are the only common exposure for cases, the ... NEWS.com.au, 17 hours ago
[x]  

692 images for hepatitis

NDTV, 17 hours ago
China Post, 1 day ago
Bidness Etc, 4 days ago
Brisbane Times, 1 day ago
Money Today, 2 days ago
NDTV Profit, 3 days ago
Manorama Online, 3 days ago
EdgeBoston.com, 1 day ago
West Australian, 1 day ago
TheJournal.ie, 2 days ago

Minister announces cut in hepatitis drug price

Islamabad - Minister for National Health Services, Regulations and Coordination Saira Afzal Tarar on Wednesday announced sharp reduction in the prices of the drug for Hepatitis C patients, Sovaldi. The current price of Rs 55,000 has been slashed ...
 The Nation Pakistan4 hours ago Price of Hepatitis C medicine cut by 40pc  DAWN Group6 hours ago

Long-Term Efficacy of a Hepatitis E Vaccine

 New England Journal of Medicine5 hours ago

Making Hepatitis E a Vaccine-Preventable Disease

 New England Journal of Medicine5 hours ago
American Banking News - Forex

Here Is Why Gilead Sciences, Inc. (GILD) Is Still Doing Better Than AbbVie Inc

Gilead Sciences, Inc. ( NASDAQ: GILD ) still remains the unrivaled leader in the hepatitis C market, as prescriptions and lives covered by competing rival, AbbVie fall far behind those covered by Gilead. Based on the prescription data released by ...
 Bidness Etc10 hours ago Gilead (GILD)'s Harvoni Achieves 96% Cure Rate in Patients With Hepatitis C and HIV 3/2/2015  ClinicSpace1 day ago 96% Hep C Cure Rate for Harvoni in Those Coinfected With HIV  AIDSmeds1 day ago Express Scripts' Miller says hepatitis C price war to save billions  Reuters1 month ago

Chinese Researchers Report Successful Hepatitis E Vaccine

By Steven Reinberg HealthDay Reporter WEDNESDAY, March 4, 2015 (HealthDay News) -- A new vaccine for hepatitis E provides protection from the virus for at least 4.5 years, according to Chinese researchers. Although hepatitis E is ...
 US News & World Report9 hours ago Hepatitis E vaccine shows strong coverage  Science News Online8 hours ago
[x]  

Roche (RHHBY) Launches Next-Generation Hepatitis B Test - Analyst Blog

Investors in the pharma/biotech sector eagerly wait for pipeline updates as they play an important role in deciding whether or not to invest in a particular company. These updates provide information on experimental drugs and at times give an ...
 Yahoo! Finance12 hours ago
Times of India

Vaccination can prevent cancers caused by human papilloma virus, Nobel laureate in medicine says

Vaccination against high-risk human papilloma virus types and hepatitis B virus can prevent specific cancers caused by them, said Nobel laureate Harald zur Hausen on Wednesday.
 Times of India18 hours ago A virus from horses is bringing us closer to a vaccine against Hepatitis C  ScienceNordic15 hours ago
NDTV

Hepatitis C: The silent epidemic

New Delhi: About 150 million people worldwide live with Hepatitis C virus infection, with the disease killing nearly 3.5 lakh people each year. In India nearly 12 million are estimated to be infected by Hepatitis C. Most infections remain ...
 NDTV17 hours ago

ALLY-2 trial demonstrates 97% SVR12 rates in patients with hepatitis C co-infected with HIV after 12-week regimen of daclatasvir and sofosbuvir

Bristol-Myers Squibb Company has announced results from ALLY-2, a Phase III clinical trial evaluating the investigational once-daily regimen of daclatasvir and sofosbuvir for the treatment of patients with chronic hepatitis C virus (HCV) co-infected ...
 Medical News Today18 hours ago Bristol-Myers: ALLY-2 Phase 3 Trial Achieves Hepatitis C Cure Rate Of 97%  RTTNews.com1 day ago Bristol Myers Squibb : ALLY Trial Demonstrates 97% Hepatitis C Cure Rates Among Patients Coinfected with HIV After Ribavirin-Free Investigational 12-Week Regimen of...  4 Traders13 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - hepatitis
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less